Literature DB >> 12902976

Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2.

Barbara Guerra1, Olaf-Georg Issinger, Jean Y J Wang.   

Abstract

Protein kinase CK2 is a serine/threonine protein kinase involved in various aspects of cellular regulation. The regulatory beta-subunit of CK2 exerts a central role not only in mediating formation of tetrameric CK2 complexes but also as a docking partner for several protein kinases. In this study, CK2beta is found to interact with the human cell cycle checkpoint kinase Chk1. The Chk1-interacting region of CK2beta is localized at the C-terminus and the complex between CK2beta and Chk1 is devoid of the catalytic CK2alpha-subunit. The interaction between CK2beta and Chk1 leads to an increase in the Cdc25C phosphorylation activity of Chk1. The screening of several cell lines has revealed that the association between CK2beta and Chk1 also occurs in vivo at a different degree. Collectively, these studies confirm the implication of the regulatory beta-subunit of protein kinase CK2 in cell cycle regulation and identify a novel mechanism for the activation of Chk1 protein kinase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902976     DOI: 10.1038/sj.onc.1206721

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Protein kinase CK2: a new view of an old molecular complex.

Authors:  Odile Filhol; Jean-Louis Martiel; Claude Cochet
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

2.  FW2.2 and cell cycle control in developing tomato fruit: a possible example of gene co-option in the evolution of a novel organ.

Authors:  Bin Cong; Steven D Tanksley
Journal:  Plant Mol Biol       Date:  2006-08-29       Impact factor: 4.076

3.  Knocking out the regulatory beta subunit of protein kinase CK2 in mice: gene dosage effects in ES cells and embryos.

Authors:  Olivier Blond; Hans H Jensen; Thierry Buchou; Claude Cochet; Olaf-Georg Issinger; Brigitte Boldyreff
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

Review 4.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

5.  Role of polyamines in determining the cellular response to chemotherapeutic agents: modulation of protein kinase CK2 expression and activity.

Authors:  Jan N Kreutzer; Birgitte B Olsen; Karolina Lech; Olaf-Georg Issinger; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

6.  CK2alpha/CK1alpha chimeras are sensitive to regulation by the CK2beta subunit.

Authors:  Ana Jedlicki; Catherine C Allende; Jorge E Allende
Journal:  Mol Cell Biochem       Date:  2008-07-12       Impact factor: 3.396

Review 7.  Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.

Authors:  Odile Filhol; Sofia Giacosa; Yann Wallez; Claude Cochet
Journal:  Cell Mol Life Sci       Date:  2015-05-20       Impact factor: 9.261

8.  Evidence for aggregation of protein kinase CK2 in the cell: a novel strategy for studying CK2 holoenzyme interaction by BRET(2).

Authors:  Gerda M Hübner; Jane Nøhr Larsen; Barbara Guerra; Karsten Niefind; Milka Vrecl; Olaf-Georg Issinger
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

9.  Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.

Authors:  Jennifer Yinuo Cao; Kathy Shire; Cameron Landry; Gerald D Gish; Tony Pawson; Lori Frappier
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

10.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.